Cargando…
A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report
Background: The outbreak of coronavirus disease 2019 (COVID-19) had become a global public health event. Lymphoma patients need to be distinguished from the general population because of their deficient immune status and intensive anti-tumor treatment. The impacts of cancer subtypes and treatment on...
Autores principales: | Li, Qiuhui, Zhu, Fang, Xiao, Yin, Liu, Tao, Liu, Xinxiu, Wu, Gang, Zhang, Liling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256193/ https://www.ncbi.nlm.nih.gov/pubmed/32574278 http://dx.doi.org/10.3389/fonc.2020.00924 |
Ejemplares similares
-
A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia
por: Zhu, Fang, et al.
Publicado: (2019) -
Successful Treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma With Evans Syndrome: A Case Report With Long-Term Follow-Up
por: Zhu, Fang, et al.
Publicado: (2020) -
Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review
por: Meng, Jingshu, et al.
Publicado: (2019) -
Synchronous double primary lymphoma and thyroid cancer: A single-institution retrospective study
por: Li, Qiuhui, et al.
Publicado: (2021) -
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up
por: Romejko-Jarosinska, Joanna, et al.
Publicado: (2022)